Overcoming Clinical Inertia in Type 2 Diabetes: Role of Endocrinologists

28th June SESSION 1: 13:00 - 14:00 I SESSION 2: 19:00 – 20:00 SAUDI ARABIA TIME

by Chantal Mathieu, Matthias Blüher, MD, and Professor Stephen Wheatcroft

Click Here To Register


The webinar will:

  • Reinforce the CV risk that accompanies T2D.
  • Revisit guidelines.
  • Shed light on clinical inertia and what it means today.


Prof. Chantal Mathieu, MD, PhD

Professor of Medicine at the Katholieke Universiteit and Chair of Endocrinology at the University Hospital Gasthuisberg Leuven, Belgium

Chantal Mathieu is a physician-scientist who has contributed to the field of diabetes and endocrinology through basic and clinical research. Her basic research work focuses on pathogenesis and prevention of type 1 diabetes. Prof. Mathieu’s clinical work involving new products and treatment paradigms in diabetes, such as new insulins, adjunct therapies and diagnosis of gestational diabetes have made her a speaker in international fora. Prof. Mathieu coordinates the European project ‘INNODIA’ on biomarker discovery and intervention studies in type 1 diabetes. Prof. Mathieu is (senior) Vice-president of the European Association for the Study of Diabetes (EASD), Chair of EASD postgraduate education and Chair of the European.


Prof. Matthias Blüher, MD

Professor of Obesity Medicine Helmholtz Institute for Metabolism, Obesity and Vasculature, Munich Faculty of Medicine, University of Leipzig, Germany

Matthias Blüher is Professor of Obesity Medicine, Director of the Helmholtz Institute for Metabolism, Obesity and Vasculature research at the Helmholtz Center Munich and the University of Leipzig, Germany. He is Speaker of the Collaborative Research Center “Obesity mechanisms” at the University of Leipzig in Leipzig, Germany. Matthias Blüher´s research is focused on the role of adipose tissue function and distribution in insulin resistance, the development of obesity, type 2 diabetes and other metabolic and cardiovascular diseases. Professor Blüher completed his medical studies at the University of Leipzig and his postdoctoral fellowship at the Joslin Diabetes Centre, Boston, USA. Matthias´ work has been recognized both nationally and internationally, as he is a recipient of the Obesity Research Award of the German Obesity Society 2003, the Ferdinand-Bertram-Prize of the German Diabetes Association 2008, EASD Rising Star Award (2010), and the Minkowski Prize of the EASD 2015.

Prof. Stephen Wheatcroft, PhD

Professor of Cardiometabolic Medicine, University of Leeds Consultant Cardiologist, Leeds Teaching Hospitals NHS Trust

Steve Wheatcroft is Professor of Cardiometabolic Medicine at the University of Leeds and Consultant Cardiologist at Leeds Teaching Hospitals NHS Trust. He graduated in Medicine from the University of Birmingham and following general medical training in the West Midlands, he trained in cardiology in the South East of England and Kings College Hospital, London. He completed a PhD in Cardiovascular Science at King’s College, London. After fellowships in coronary intervention in Krakow and Prague, he joined the University of Leeds as an academic cardiologist in 2006. Steve leads a vascular biology research group in Leeds focused on the effects of diabetes and insulin resistance on the cardiovascular system. Working at one of the UK’s highest volume heart attack centres, he has clinical interests in coronary artery intervention, acute coronary syndromes and cardiovascular risk reduction. He is passionate about reducing cardiovascular risk in people with cardiovascular disease, diabetes or chronic kidney disease. Steve is chair of CaReMe-UK, a collaboration between the British Cardiovascular Society, Association of British Clinical Diabetologists, UK Kidney Association, Primary Care Cardiovascular Society and Primary Care Diabetes Society.


Click Here To Register

Share this Webinar

Sponsored by Eli Lilly

Or register using the form below: